Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bacteriophage therapeutics - BiomX

Next Previous
X
Search
Drug Profile

Bacteriophage therapeutics - BiomX

Alternative Names: PhageBank based therapeutics - BiomX; PhageBankTM; PhageBank®; WRAIR-PAM-CF1; WRAIR_PAM-CF1

Latest Information Update: 05 Apr 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Naval Medical Research Center; Walter Reed Army Institute of Research
  • Developer BiomX; National Institute of Allergy and Infectious Diseases
  • Class Anti-infectives; Antibacterials; Bacteriophages
  • Mechanism of Action Bacterial growth inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Bone and joint infections
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Cystic fibrosis-associated respiratory tract infections; Osteomyelitis; Urinary tract infections
  • Preclinical Bone and joint infections
  • No development reported Bacterial infections

Most Recent Events

  • 01 Apr 2024 Adaptive Phage Therapeutics has been acquired and merged into BiomX
  • 28 Dec 2023 No recent reports of development identified for clinical-Phase-Unknown development in Bacterial-infections in USA (IV)
  • 13 Mar 2023 Adaptive Phage Therapeutics terminates a phase I/II BEUTIFL trial in Urinary tract infections in USA (IV) (Intravesicular) due to change in development strategy (NCT04287478)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top